Login / Signup

Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Xu ZhouDong-Mei YanWei-Feng ZhuWen-Jun LiuHe-Yun NieSheng XuYi-Ping JiangKun-He ZhangYing FuYi-Ye WanXin-Yu YuHong LiXin SunXiao-Fan Chen
Published in: Trials (2019)
ClinicalTrials.gov, NCT03025152 . Registered on 17 January 2017.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • randomized controlled trial
  • study protocol
  • case report
  • replacement therapy
  • open label